IMP-362

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIMP-362

Drug Alias NamehLAG-3 + Gag and Nef antigen fusion protein vaccine (Immutep)IMP-362

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionLymphocyte activation gene 3 protein modulatorsGlycosaminoglycan modulatorsProtein Nef modulators

TargetsLymphocyte activation gene 3 proteinGlycosaminoglycanProtein Nef

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmutep SAS

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmutep SAS

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A